Press Releases

Providing Company with Additional Shares to Execute Against Strategic Plan to Accelerate Growth and Drive Value Creation NEW YORK & LEAMINGTON, Ontario --(BUSINESS WIRE)--Sep. 10, 2021-- Tilray, Inc. (“ Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer

NEW YORK & LEAMINGTON, Ontario --(BUSINESS WIRE)--Sep. 8, 2021-- Tilray, Inc. (“ Tilray”) (NASDAQ | TSX: TLRY) a leading global cannabis-lifestyle and consumer packaged goods company, announced today that Irwin D Simon, Chairman and Chief Executive Officer, Tilray , and Carl Merton , Chief

Reiterates Need for Stockholder Support in Advance of Special Meeting -- Stockholders Who Support the Plan Should Vote Prior to the Special Stockholders Meeting on September 10 -- NEW YORK & LEAMINGTON, Ontario --(BUSINESS WIRE)--Aug. 26, 2021-- Tilray, Inc. (“ Tilray” or the “Company”) (NASDAQ |

Votes already cast point to support for both the Authorized Shares Proposal and the Governance Proposals Tilray urges stockholders to vote immediately in support of long-term value creation NEW YORK & LEAMINGTON, Ontario --(BUSINESS WIRE)--Aug. 19, 2021-- Tilray, Inc.

Investment Provides Tilray a Potential Accelerated Path into U.S. Cannabis Market Upon Federal Legalization Amendment and Extension of Convertible Notes Enables MedMen to Reshape Balance Sheet and Further Accelerate its Growth Trajectory Tilray and MedMen CEOs to Host a Conference Call and Webcast

New Product Innovations Respond to Patient Needs Across Medical Category NEW YORK & LEAMINGTON, Ontario --(BUSINESS WIRE)--Aug. 5, 2021-- Tilray, Inc. (“ Tilray”) (Nasdaq I TSX: TLRY), a global pioneer in medical cannabis research, cultivation, and production, today announced the launch of medical

Preliminary assessment of votes already cast points to overwhelming support for both the Authorized Shares Proposal and the Governance Proposals Tilray urges stockholders to vote immediately in support of long-term value creation NEW YORK & LEAMINGTON, Ontario --(BUSINESS WIRE)--Jul.

Net Revenue Increased 27% to $513 Million Compared to Prior Year Net Income of $33.6 Million , Adjusted EBITDA of $12.3 Million , Net Cash from Operating Activities of $8.3 Million and Positive Free Cash Flow of $3.3 Million in Q4 Completed Business Combination with Aphria Inc., Achieved $35

Tilray urges shareholders to vote today in support of long-term value creation NEW YORK & LEAMINGTON, Ontario --(BUSINESS WIRE)--Jul. 21, 2021-- Tilray, Inc. (“ Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced

NEW YORK & LEAMINGTON, Ontario --(BUSINESS WIRE)--Jul. 15, 2021-- Tilray, Inc. (“ Tilray” or the “Company”) (NASDAQ: TLRY; TSX: TLRY) announced that the Company will release financial results for its fourth quarter and fiscal year 2021 ended May 31, 2021 before financial markets open on Wednesday,